Delivery Order SPE2DB20D1100-SPE2DB25FC1H7
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,150.03, is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price delivery order. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.88, is a delivery order for the medical product "ADBRY 300 MG/2 ML AUTOINJECTOR 2ML". The contract has an ultimate completion date of April 10, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML medical supplies. The contract, valued at $3,704.75, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of October 17, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of a pharmaceutical product, ADBRY 150 MG/ML SYRINGEML. The contract has a ceiling value of $12,125.82 and an ultimate completion date of August 30, 2024. It is a firm fixed-price contract and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The company holds several Indefinite...
This federal contract award, valued at $31,354.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a pharmaceutical product. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product - ADBRY 150 MG/ML SYRINGEML. The order has a ceiling value of $17,638.32 and a period of performance through August 13, 2024. It is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999, which provides a broad range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $31,627.00 and a period of performance through May 30, 2024. It is for the procurement of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price, delivery order, and does not have a set-aside designation. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,041.76 firm fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,028.98 contract is for the delivery of ADBRY 150 MG/ML SYRINGEML pharmaceutical products to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $3,062.64 and a period of performance through January 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...